Optus Pharmaceutical Co Ltd
131030
Company Profile
Business description
Optus Pharmaceutical Co Ltd is a pharmaceutical company focused on the development, production, and sale of ophthalmic treatments, including those for dry eye, glaucoma, and anti-inflammatory treatments.
Contact
50 Osongsaengmyeong 6-ro
Osong-eup
Heungdeok-gu, Chungcheongbuk-do
Cheongju-si28158
KORT: +82 221180030
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
249
Stocks News & Analysis
stocks
This ASX miner is the cheapest in our iron ore coverage
High debt levels and low commodity prices were a concern, but agreed sell-downs and a ramp-up of key operations should help.
stocks
Apple names new CEO as Tim Cook steps aside after 15 years
John Ternus, Apple’s hardware chief, will take up the role in September.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,079.90 | 45.30 | -0.50% |
| CAC 40 | 8,235.72 | 95.32 | -1.14% |
| DAX 40 | 24,270.87 | 146.93 | -0.60% |
| Dow JONES (US) | 49,149.38 | 293.18 | -0.59% |
| FTSE 100 | 10,498.09 | 110.99 | -1.05% |
| HKSE | 26,137.01 | 350.47 | -1.32% |
| NASDAQ | 24,259.96 | 144.43 | -0.59% |
| Nikkei 225 | 59,414.44 | 65.27 | 0.11% |
| NZX 50 Index | 12,931.74 | 0.59 | -0.00% |
| S&P 500 | 7,064.01 | 45.13 | -0.63% |
| S&P/ASX 200 | 8,852.50 | 44.30 | -0.50% |
| SSE Composite Index | 4,095.07 | 10.00 | 0.24% |